December 16, 2025
RNAConnect, a life science company providing next generation tools to the RNA community, today announced the commercial availability of the UltraMarathonRT® Direct RNA‑Seq (uMRT DRS) Kit, a native‑RNA library preparation solution for Oxford Nanopore Technologies® direct RNA sequencing (SQK-RNA004). The kit enables the detection of more genes, more isoforms, and longer transcripts than existing protocols. It [...]
December 16, 2025
BONADUZ, Switzerland -- Hamilton today announced the launch of GlucoSense, a breakthrough in bioprocess analytics that introduces the first reusable, in situ glucose sensor designed to deliver continuous, real-time measurements directly inside cell culture bioreactors. With this release, Hamilton is establishing an entirely new category of process sensors intended to make glucose control as routine and [...]
Aptamer signs licensing agreement with Twist Bioscience
December 16, 2025
Non-exclusive license for Optimer® binder targeting the next-generation sequencing market Aptamer Group plc, the developer of next-generation synthetic binders for the life sciences industry, is pleased to announce a first licensing agreement with Twist Bioscience, a leading synthetic biology and genomics company. Under the terms of the agreement, Aptamer has granted Twist Bioscience a non-exclusive [...]
December 16, 2025
New AI Models-as-a-Service offering to integrate in-silico design with experimental data to continuously improve predictive power and accelerate scientific innovation WALTHAM, Mass. -- Revvity, Inc. (NYSE: RVTY) today announced the introduction of its forthcoming Signals Xynthetica™ Models-as-a Service (MaaS) AI offering within the Revvity Signals platform. The Signals Xynthetica offering will enable AI-augmented molecular and materials design, and brings together [...]
Repligen Introduces Next-Generation Chromatography Resins to Advance New Modality Workflows
December 16, 2025
WALTHAM, Mass. -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the launch of three new high-performance chromatography resins: AVIPure® HiPer™ AAV9 and AVIPure® HiPer™ AAV8 affinity resins, along with HiPer™ QA anion exchange resin, expanding the company’s growing proteins portfolio and reinforcing its commitment to innovation in next-generation bioprocessing. [...]
December 16, 2025
We launched the ChemiSphere app, a digital tool for scientists to instantly access product documentation and quality information via 2D barcodes. Connects physical products directly to digital workflows to reduce manual steps and boost efficiency Enables instant access to product documentation such as safety data sheets (SDS) and certificates of analysis (CoA) Built on the [...]
ATS Announces Doug Wright as Chief Executive Officer
December 16, 2025
CAMBRIDGE, Ontario--ATS Corporation (TSX: ATS) (NYSE: ATS) (“ATS” or the “Company”) today announced that Doug Wright has been appointed Chief Executive Officer (CEO) and a member of its Board of Directors, commencing on or before January 14, 2026. Mr. Wright’s appointment follows a comprehensive search led by ATS’ Board of Directors. "We are very pleased [...]
December 15, 2025
New formulations simplify microbial bioprocessing, helping innovators scale plasmid DNA and protein production with confidence WALTHAM, Mass. -- Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of Gibco™ Bacto™ CD Supreme FPM Plus and Gibco™ Bacto™ CD Supreme Feed (2X), two next-generation chemically-defined formulations that expand the Gibco™ Bacto™ [...]
Pixelgen Technologies Further Expands Asia Presence Through Distribution Agreement with MDxK
December 15, 2025
Agreement brings Pixelgen Proxiome Kit to South Korea as demand for protein interactome's tools grows STOCKHOLM -- Pixelgen Technologies, Inc. and MDxK (Molecular Diagnostics Korea) Inc., part of DKSH Business Unit Technology, a leader in market expansion services, today announced a distribution agreement to bring Pixelgen's Proxiome Kit to life sciences researchers in South Korea. The agreement further expands [...]
December 15, 2025
TAIPEI -- Leadgene Biosolutions, Inc. (formerly CYTENA BPS), following its transition out of the BICO Group, now officially integrates with Leadgene Biomedical, a biotechnology company specializing in recombinant proteins, antibodies, and diagnostic reagent development with integrated CRO/CDMO services. This alignment enables the combined organization to offer a full suite of bioprocessing products, solutions, and services across [...]

